Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Age-group
1.2.4. Consumer Group
1.2.5. Sales Channel
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Outlook
2.2.2. Application Outlook
2.2.3. Age-group Outlook
2.2.4. Consumer Group Outlook
2.2.5. Sales Channel Outlook
2.3. Competitive Insights
Chapter 3. U.S. Women’s Health And Beauty Supplements Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.3. U.S. Women’s Health And Beauty Supplements Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. U.S. Women’s Health And Beauty Supplements Market: Product Estimates & Trend Analysis
4.1. U.S. Women’s Health And Beauty Supplements Market: Product Dashboard
4.2. U.S. Women’s Health And Beauty Supplements Market: Product Movement Analysis
4.3. U.S. Women’s Health And Beauty Supplements Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.4. Vitamins
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Mineral
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Enzymes
4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Botanicals
4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Proteins
4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.9. Omega - 3
4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.10. Probiotics
4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.11. Other Products
4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Women’s Health And Beauty Supplements Market: Application Estimates & Trend Analysis
5.1. U.S. Women’s Health And Beauty Supplements Market: Application Dashboard
5.2. U.S. Women’s Health And Beauty Supplements Market: Application Movement Analysis
5.3. U.S. Women’s Health And Beauty Supplements Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4. Beauty
5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Skin Care
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Nail Care
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Hair Care
5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Other Applications
5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Women’s Health
5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Women’s Health And Beauty Supplements Market: Age-group Estimates & Trend Analysis
6.1. U.S. Women’s Health And Beauty Supplements Market: Age-group Dashboard
6.2. U.S. Women’s Health And Beauty Supplements Market: Age-group Movement Analysis
6.3. U.S. Women’s Health And Beauty Supplements Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.4. Age 15 - 30
6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Age 31-50
6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Age 51-70
6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Above 70 years
6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. U.S. Women’s Health And Beauty Supplements Market: Consumer Group Estimates & Trend Analysis
7.1. U.S. Women’s Health And Beauty Supplements Market: Consumer Group Dashboard
7.2. U.S. Women’s Health And Beauty Supplements Market: Consumer Group Movement Analysis
7.3. U.S. Women’s Health And Beauty Supplements Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.4. Prenatal
7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Postnatal
7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.6. PMS
7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Perimenopause
7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Postmenopause
7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.9. Other Consumer Groups
7.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. U.S. Women’s Health And Beauty Supplements Market: Sales Channel Estimates & Trend Analysis
8.1. U.S. Women’s Health And Beauty Supplements Market: Sales Channel Dashboard
8.2. U.S. Women’s Health And Beauty Supplements Market: Sales Channel Movement Analysis
8.3. U.S. Women’s Health And Beauty Supplements Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.4. Online
8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.5. Direct Sales
8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Pharamcies/Drug Stores
8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Other Offline Channels
8.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Herbalife International of America, Inc.
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. GNC Holdings, Inc
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. Nature’s Bounty
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Bayer AG
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Suntory Holdings Limited
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Taisho Pharmaceutical Co., Ltd
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Pharmavite LLC
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. Pfizer, Inc
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Blackmores
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. FANCL Corporation
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.3.14. Asahi Group Holdings, Ltd
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Product benchmarking
9.3.14.4. Strategic initiatives
9.3.15. USANA Health Sciences, Inc.
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Product benchmarking
9.3.15.4. Strategic initiatives
9.3.16. Nu Skin Enterprise, Inc.
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Product benchmarking
9.3.16.4. Strategic initiatives
9.3.17. BY-HEALTH Co., Ltd.
9.3.17.1. Company overview
9.3.17.2. Financial performance
9.3.17.3. Product benchmarking
9.3.17.4. Strategic initiatives
9.3.18. Revital Ltd
9.3.18.1. Company overview
9.3.18.2. Financial performance
9.3.18.3. Product benchmarking
9.3.18.4. Strategic initiatives
9.3.19. The Himalaya Drug Company
9.3.19.1. Company overview
9.3.19.2. Financial performance
9.3.19.3. Product benchmarking
9.3.19.4. Strategic initiatives
9.3.20. Vita Life Sciences
9.3.20.1. Company overview
9.3.20.2. Financial performance
9.3.20.3. Product benchmarking
9.3.20.4. Strategic initiatives
9.3.21. Standard Foods Corporation
9.3.21.1. Company overview
9.3.21.2. Financial performance
9.3.21.3. Product benchmarking
9.3.21.4. Strategic initiatives
9.3.22. Garden of Life (Nestlé)
9.3.22.1. Company overview
9.3.22.2. Financial performance
9.3.22.3. Product benchmarking
9.3.22.4. Strategic initiatives
List of Tables
Table 1. List of abbreviation
Table 2. U.S. women’s health and beauty supplements market, 2018 - 2030 (USD Million)
Table 3. U.S. women’s health and beauty supplements market, by product, 2018 - 2030 (USD Million)
Table 4. U.S. women’s health and beauty supplements market, by application, 2018 - 2030 (USD Million)
Table 5. U.S. women’s health and beauty supplements market, by age-group, 2018 - 2030 (USD Million)
Table 6. U.S. women’s health and beauty supplements market, by consumer group, 2018 - 2030 (USD Million)
Table 7. U.S. women’s health and beauty supplements market, by sales channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 U.S. women’s health and beauty supplements market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Product and stage segment snapshot
Fig. 11 Sales channel segment snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s five forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. women’s health and beauty supplements market: Product outlook and key takeaways
Fig. 16 U.S. women’s health and beauty supplements market: Product movement analysis
Fig. 17 Vitamins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Mineral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Botanicals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Proteins market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Omega - 3 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Probiotics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Other products market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 U.S. women’s health and beauty supplements market: Application outlook and key takeaways
Fig. 26 U.S. women’s health and beauty supplements market: Application movement analysis
Fig. 27 Beauty market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Skin care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Nail care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Hair care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Women’s health market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 U.S. women’s health and beauty supplements market: Age-group outlook and key takeaways
Fig. 34 U.S. women’s health and beauty supplements market: Age-group movement analysis
Fig. 35 Age 15 - 30 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Age 31-50 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Age 51-70 market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Above 70 years market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 U.S. women’s health and beauty supplements market: Consumer group outlook and key takeaways
Fig. 40 U.S. women’s health and beauty supplements market: Consumer group movement analysis
Fig. 41 Prenatal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Postnatal market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 PMS market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Perimenopause market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Postmenopause market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Other consumer groups market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 U.S. women’s health and beauty supplements market: Sales channel outlook and key takeaways
Fig. 48 U.S. women’s health and beauty supplements market: Sales channel movement analysis
Fig. 49 Online market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Direct sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Pharamcies/drug stores market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Other offline channels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Company market share analysis, 2023
Fig. 54 Strategic framework